Related Experiment Videos
Teratogenic effects and distribution of cadmium (Cd2+) administered via osmotic minipumps to gravid CF-1 mice
M P Mahalik1, H W Hitner, W C Prozialeck
1Department of Pharmacology, Lake Erie College of Osteopathic Medicine, PA 16509, USA.
Abstract:
Studies to identify the mechanisms underlying the teratogenic effects of cadmium (Cd2+) have been complicated by the inherent difficulties of chronically and subchronically administering specific doses of Cd2+ to gravid animals under strictly controlled conditions. The objective of the present study was to develop a relatively simple animal model for examining the teratogenic effects of subchronic Cd2+ exposure. Cd2+ was administered to gravid CF-1 mice by subcutaneously implanted Alzet osmotic minipumps, which released fixed amounts of Cd2+ over a 14-day period between days 5 and 18 of gestation. The results showed that Cd2+ administered in this manner produced fetal anomalies and that the patterns of Cd2+ distribution and the specific developmental defects were similar to those that have been reported for other routes of Cd2+ administration. These findings indicate that osmotic minipumps may serve as useful tools in long-term studies of Cd2+ teratogenicity. They would appear to be especially useful in teratogenic evaluations where minimizing maternal stress and administering precise doses of Cd2+ are important.
Insights
This study introduces a simpler animal model for cadmium (Cd2+) teratogenicity research. Osmotic minipumps effectively delivered precise Cd2+ doses, causing fetal anomalies similar to other methods.
Area of Science:
- Toxicology
- Developmental Biology
- Animal Models
Background:
- Identifying cadmium's (Cd2+) teratogenic mechanisms is challenging due to difficulties in precise dose administration.
- Existing methods for studying subchronic cadmium exposure in pregnant animals are complex and may induce maternal stress.
Purpose of the Study:
- To develop a simplified animal model for investigating the teratogenic effects of subchronic cadmium (Cd2+) exposure.
- To assess the utility of osmotic minipumps for controlled cadmium delivery in pregnant mice.
Main Methods:
- Gravid CF-1 mice were administered cadmium (Cd2+) via subcutaneously implanted Alzet osmotic minipumps.
- Cadmium delivery occurred over a 14-day period, from day 5 to day 18 of gestation.
- This method aimed to provide fixed, controlled doses of Cd2+ while minimizing maternal stress.
Main Results:
- Cadmium (Cd2+) administration using osmotic minipumps resulted in the development of fetal anomalies.
- The observed patterns of Cd2+ distribution and specific developmental defects mirrored those from previous studies using different administration routes.
- The minipump method proved effective in delivering precise Cd2+ doses during critical developmental periods.
Conclusions:
- Osmotic minipumps offer a valuable and simplified tool for long-term studies on cadmium (Cd2+) teratogenicity.
- This model is particularly advantageous for teratogenic evaluations requiring minimized maternal stress and accurate cadmium dosing.
- The findings support the use of osmotic minipumps for reliable investigation of environmental teratogens.